Lobbying client

VAXXAS INC

Vaccine Research

Filings
17
Filed by
1
Reported in-house
—
Reported by firms
$130,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2022 to 2026

Filings

17 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2026
THE CONAFAY GROUP, LLC — reported
4th Quarter - Report (No Activity)
4th Quarter 2025
THE CONAFAY GROUP, LLC — reported
3rd Quarter - Report
3rd Quarter 2025
THE CONAFAY GROUP, LLC — reported
2nd Quarter - Report
2nd Quarter 2025
THE CONAFAY GROUP, LLC $10,000 reported
1st Quarter - Report
1st Quarter 2025
THE CONAFAY GROUP, LLC $10,000 reported
4th Quarter - Report
4th Quarter 2024
THE CONAFAY GROUP, LLC $10,000 reported
3rd Quarter - Report
3rd Quarter 2024
THE CONAFAY GROUP, LLC $10,000 reported
2nd Quarter - Report
2nd Quarter 2024
THE CONAFAY GROUP, LLC $10,000 reported
1st Quarter - Report
1st Quarter 2024
THE CONAFAY GROUP, LLC $10,000 reported
4th Quarter - Report
4th Quarter 2023
THE CONAFAY GROUP, LLC $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE CONAFAY GROUP, LLC 16 $130,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medical/Disease Research/Clinical Labs MED 15

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.